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Background: Ranking and identifying biomarkers that are associated with disease from genome-wide measurements
holds significant promise for understanding the genetic basis of common diseases. The large number of single
nucleotide polymorphisms (SNPs) in genome-wide studies (GWAS), however, makes this task computationally
challenging when the ranking is to be done in a multivariate fashion. This paper evaluates the performance of a
multivariate graph-based method called label propagation (LP) that efficiently ranks SNPs in genome-wide data.
Results: The performance of LP was evaluated on a synthetic dataset and two late onset Alzheimer’s disease
(LOAD) genome-wide datasets, and the performance was compared to that of three control methods. The control
methods included chi squared, which is a commonly used univariate method, as well as a Relief method called
SWRF and a sparse logistic regression (SLR) method, which are both multivariate ranking methods. Performance
was measured by evaluating the top-ranked SNPs in terms of classification performance, reproducibility between
the two datasets, and prior evidence of being associated with LOAD.
On the synthetic data LP performed comparably to the control methods. On GWAS data, LP performed significantly
better than chi squared and SWRF in classification performance in the range from 10 to 1000 top-ranked SNPs for both
datasets, and not significantly different from SLR. LP also had greater ranking reproducibility than chi squared, SWRF, and
SLR. Among the 25 top-ranked SNPs that were identified by LP, there were 14 SNPs in one dataset that had evidence in
the literature of being associated with LOAD, and 10 SNPs in the other, which was higher than for the other methods.
Conclusion: LP performed considerably better in ranking SNPs in two high-dimensional genome-wide datasets
when compared to three control methods. It had better performance in the evaluation measures we used, and is
computationally efficient to be applied practically to data from genome-wide studies. These results provide support for
including LP in the methods that are used to rank SNPs in genome-wide datasets.
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The volume of genomic data generated from genome-
wide association studies (GWASs) is growing at an
exponential rate, in large part due to the decreasing
cost of high-throughput genotyping technologies. A
GWAS measures hundreds of thousands of single
nucleotide polymorphism (SNPs) across the human gen-
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reproduction in any medium, provided the orthat results when a single nucleotide is replaced by
another in the genome sequence. The goal of a GWAS
is typically biomarker discovery, that is, to discover
SNPs that either singly or in combination are associ-
ated with the disease of interest. The high dimensional-
ity of GWAS data poses statistical and computational
challenges in identifying associations between SNPs
and disease efficiently and accurately.
The typical analysis of GWAS data involves the ap-
plication of a univariate feature ranking method that
evaluates each SNP’s strength of association with disease in-
dependently of all other SNPs. For example, the chi squared
statistic is used to assess the expected and observed geno-
types of a SNP in cases and controls in a GWAS, and ranksLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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the advantage of being are computationally efficient;
however, they cannot capture interactions among genes
and such interactions may play an important role in
genetic basis of disease. Moreover, univariate methods
may be associated with lack of reproducibility across
datasets; that is, SNPs found to be relevant in one study
do not show an association in another. Multivariate
feature ranking methods evaluate each SNP’s strength
of association with disease in the context of other SNPs.
For example, Relief is capable of detecting complex
SNP-SNP dependencies even in the absence of main
effects. However, multivariate methods are computa-
tionally demanding since they consider the strength of
association with disease of combinations of SNPs.
This paper describes the application of an efficient and
stable multivariate machine learning method called label
propagation (LP). LP has been applied successfully on
other types of biological data, including gene expression
and protein concentration data [1]; however, to our know-
ledge, the method has not been applied to datasets with a
very large number of features as found in GWASs. We
apply LP to two Alzheimer’s disease GWAS datasets. We
conjectured that it would be efficient, produce reprodu-
cible rankings of SNPs and perform well. A positive result
would support using LP in analyzing other genome-wide
datasets, including next-generation genome-wide datasets
that contain even larger number of SNPs.
The following sections provide background informa-
tion about genome-wide association studies, feature
ranking methods, and Alzheimer’s disease.
Genome-wide association studies
In a GWAS, high-throughput genotyping technologies are
used to assay hundreds of thousands or even millions of
SNPs across the genome in a cohort of cases and controls.
Since the advent of GWASs many common diseases,
including Alzheimer’s disease, diabetes, and heart dis-
ease have been studied with the goal of identifying the
underlying genetic variations. The success of GWASs
in identifying genetic variants associated with a disease
rests on the common disease-common variant hypoth-
esis. This hypothesis posits that common diseases are
caused usually by relatively common genetic variants
and individually many of these variants have low pene-
trance and hence have small to moderate association
with the disease [2].
In the past decade, GWASs have been moderately
successful and have identified approximately 4,500
common disease-associated SNVs, and several hundred
of the SNVs have been replicated [3]. A possible reason
for the moderate success of GWASs is the common
disease-rare variant hypothesis, which posits that many
rare variants underlie common diseases and each variantcauses disease in relatively few individuals with high pene-
trance [2]. However, larger sample sizes and new analytical
methods will likely make GWASs useful for detecting rare
variants as well [4].
Feature selection and feature ranking methods
High-throughput genotyping and other biological tech-
nologies offer the promise of identifying sets of features
that represent biomarkers for use in biomedical applica-
tions. The challenge with these high-dimensional data is
that the selection of a small set of features or the rank-
ing of all features requires robust feature selection and
feature ranking methods.
A range of selection and feature ranking methods have
been developed and a recent review of the methods is
provided in [5]. There are two major families of feature
selection methods, namely, filter methods and wrapper
methods. Filter methods evaluate features directly inde-
pendent of how the features will be used subsequently.
In contrast, wrapper methods evaluate features in the
context of the how they will be used. For example, if fea-
tures are to be used subsequently to develop a classifica-
tion model, a wrapper method evaluates the goodness of
features in terms of their ability to improve the perform-
ance of the classification model.
Filter methods assess the relevance of features by
examining only the intrinsic properties of the data.
Univariate filter methods compute the relevance of
each feature independently of other features. They are
computationally fast and scale to high-dimensional
data because the complexity is linear in the number of
features and interactions between features are ignored.
Typically, such methods compute a statistic or a score
for each feature such as chi squared or information
gain. Multivariate filter methods model correlations
and dependencies among the features; they are computa-
tionally somewhat slower and may be less scalable to
high-dimensional data. Examples of multivariate methods
include correlation-based feature selection and Markov
blanket feature selection.
The chi squared statistic is commonly used in SNP
analysis is a univariate filter method. This test measures
whether outcome distributions are significantly different
among SNP states, indicating features that have an
impact on disease. The chi squared statistic is very fast
to compute and has a simple statistical interpretation.
However, it cannot detect higher-order effects such as
SNPs that interact to produce an effect on disease.
The Relief method [6] is a multivariate filter method
that has been applied to SNP data to rank SNPs. This
method computes the relevance of a SNP by examining
patterns in a local neighborhood of training samples.
The method examines whether, among reasonably simi-
lar samples, a change in SNP state is accompanied by a
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interaction effects by means of the neighborhood locality
measure, but does so at the cost of increased computa-
tion time. Relief has been adapted in several ways for
application to SNP data. The most recently described
adaptations of Relief include Spatially Uniform ReliefF
(SURF) [7,8] and Sigmoid Weighted ReliefF (SWRF) [9]
that were developed specifically for application to high-
dimensional SNP data.
Logistic regression is another commonly used multi-
variate method that has been applied to many bioinfor-
matics tasks for both classification and feature ranking.
More recently, sparse logistic regression (SLR) models
which are implicitly feature-selective have been devel-
oped for high-dimensional data. SLR uses L1-norm
regularization that drives the weights of many of the
features to zero, and has been used successfully as a
feature selection method in high-dimensional biomed-
ical data, including fMRI imaging data [10] and genomic
data [11].
One challenge of feature ranking in genomic data
arises from the observation that a group of SNPs that
are in linkage disequilibrium (LD) will be statistically
correlated and can lead to redundancy when many of
the top-ranked variants represent the same genetic sig-
nal. This is particularly an issue with univariate tests
like chi squared, which operate solely on observational
data counts. With such a test, SNPs that have near-
identical case–control distributions will be assigned
near-identical scores. The problem is mitigated some-
what by multivariate methods that utilize locality or
other inference. By considering the context of each
attribute, even SNPs with near-identical case–control
distributions may be assigned different scores based on
the context of surrounding SNPs.
Alzheimer’s disease
Alzheimer’s disease (AD) is a neurodegenerative disease
characterized by slowly progressing memory failure,
confusion, poor judgment, and ultimately, death [12]. It
is the most common form of dementia associated with
aging. There are two forms of AD, called familial AD
and sporadic AD. The rarer form is early-onset familial
AD, which typically begins before 65 years of age. The
genetic basis of early-onset AD is well established, and
it exhibits an autosomal dominant mode of inheritance.
Most familial cases of AD are accounted for by muta-
tions in one of three genes (amyloid precursor protein
gene, presenelin 1 or presenelin 2).
Sporadic AD, also called late-onset AD (LOAD), is the
commoner form of AD, accounting for approximately 95%
of all AD cases. The onset of LOAD symptoms typically
occurs after 65 years age. LOAD has a heritable compo-
nent, but has a more genetically complex mechanism thanfamilial AD. The strongest consistently replicated genetic
risk factor for LOAD is the apolipoprotein E (APOE)
gene. Two genetic loci (rs429358 and rs7412) together
determine the allele of the APOE gene, which are called
APOE*2, APOE*3 and APOE*4. The APOE*4 allele is a
LOAD risk factor, while the APOE*2 allele is associated
with reduced risk [13].
In the past several years, GWASs have identified
several additional genetic loci associated with LOAD.
Over a dozen significantly associated loci have been pub-
lished in the literature, resulting from meta-analyses of
several AD GWASs [14-16].
Label propagation
This section first provides an overview of the label propa-
gation and then provides more details of the method.
Overview
LP is a machine learning method that can be used for
prediction (e.g., predicting case/control status from SNP
measurements on a sample) and as a multivariate feature
ranking method (e.g., ranking SNPs in a case/control
GWAS dataset). It is graph-based algorithm that repre-
sents the data as a bipartite graph. A bipartite graph
contains two sets of nodes (i.e., sample nodes that repre-
sent individuals and feature nodes that represent SNPs
in GWAS data) and edges that link nodes from one set
to nodes in the other set. The sample nodes are labeled
with case/control status, and LP diffuses the labels across
graph edges to the feature nodes and back again, until a
stable solution is reached. The solution results in a final
labeling of all nodes in the graph, including the feature
nodes, which balances the diffusion of the labels with
consistency with the original labeling. The labeling of the
feature nodes can be used to rank the features, and the
labeling of the sample nodes can be used as predictions.
The LP method scales well for thousands of samples
and features. It has complexity O(kNF), where N is the
number of samples, F is the number of features and k
is the number of iterations required for convergence.
Typically, k is much smaller than N or F, which makes
LP a relatively fast method. LP is able to handle missing
data and both continuous and discrete data.
Because of its wide applicability, fast running time,
and multivariate nature, LP has been applied to several
bioinformatics problems. LP has been used in breast
cancer gene expression data in order to find functional
modules of co-expressed genes [17]. It has been applied
to gene function prediction, utilizing known gene func-
tions and interactions to infer the function of other
genes [18]. It has shown success in classifying patients
with Alzheimer’s disease using protein array data [19].
To our knowledge, LP has not been applied to SNP data.
Unique challenges in the SNP domain include a much
Figure 1 A small bipartite graph for a hypothetical dataset
with five samples and two SNPs. The five samples are represented
by the nodes at the left (V), and are labeled with case or control status
(+1, −1, respectively). Each SNP is represented by three nodes at the
right (U) with one node for each SNP state (AA =major homozygote,
Aa = heterozygote, aa =minor homozygote). Edges represent actual
observations in the dataset and connect samples to the SNP states
that they exhibit. Labels are allowed to propagate along edges
and result in a final labeling for each node in the range (−1, +1),
indicating association with case or control status.
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sands), as well as the discrete, nominal nature of SNP
states (as opposed to the continuous nature of expres-
sion data).
Algorithmic details
We represent a GWAS dataset as a bipartite graph G =
(V, U, E) which consists of two sets of nodes V and U
where nodes in V represent samples (individuals) and
nodes in U represent features (SNP states). Note that if a
SNP has three states (major homozygote, heterozygote
and minor homozygote) than it will be represented by
three nodes in U. In addition to the two sets of nodes,
the graph contains a set of edges E where each edge
links a node in V with a node in U. An edge E(v,u) that
links node v with node u is associated with a link weight
w(v, u) =1. These edges connect sample nodes to feature
nodes, representing the presence of SNP state u in indi-
vidual v. Initial labels y(v) and y(u) are applied to nodes,
and take values {−1, 0, +1}, representing known training
information about case/control status (+1 and −1, re-
spectively), or a lack of information (0). An example
graph initialization is shown in Figure 1.
Given the graph initialization, the propagation algo-
rithm finds an optimal assignment of node labels f(v)
and f(u), which minimizes the objective function
Q fð Þ ¼
X
v;uð Þ∈Ew v; uð Þ
f vð Þﬃﬃﬃﬃﬃﬃﬃﬃﬃ







f vð Þ−y vð Þð Þ2 þ
X
u∈U
f uð Þ−y uð Þð Þ2
 
where μ is a parameter controlling the relative effect of
the two parts of the cost function.
The first part of the equation is a smoothness con-
straint, ensuring that strongly connected nodes in V and
U get similar labels. Here, d(v) and d(u) are the degree
of each node in V and U, such that d(v) = ∑ (v,u) ∈ Ew(v, u)
and d(u) = ∑ (v,u) ∈ Ew(v, u). The second part of the equa-
tion is a fitting constraint. For labeled nodes, this en-
sures that nodes labels are consistent with the initial
labeling. For unlabeled nodes, this term constrains the
overall cost. In the discrete-label case where f→ {−1, 0, +1},
the optimization of this cost function is NP-hard. By relax-
ing the labels so that f → R, however, the optimization of
this equation becomes straightforward as derived in Zhou
[20], and has the solution f ∗ = (1 − α)(I − αS)− 1Y. Here, I
is the identity matrix and S is the normalized connectivity












, where W is
the |V| × |U| sized matrix of edge weights and DV and DU
are the |V| × |V| and |U| × |U| diagonal matrices contain-
ing node degrees, respectively.While the solution may be computed directly by alge-
braic evaluation, it requires the inversion of a T × T
matrix where T is the total number of nodes in the net-
work (T = |V| + |U|). This requires between O(T2) and O
(T3) time, depending on the inversion method used. In-
stead, we use an iterative procedure that diffuses node
labels from one node set to another. First, the normal-
ized graph Laplacian is computed as B ¼ D−1=2V WD
−1=2
U .
This is a special encoding of the graph which represents
node degrees and adjacency. It has an interpretation as a
random walk transition matrix, allowing labels to travel
across graph edges. The node labels on V and U are
computed iteratively as
f tþ1 Vð Þ ¼ 1−αð Þy Vð Þ þ αBf t Uð Þ and
f tþ1 Uð Þ ¼ 1−αð Þy Uð Þ þ αBf t Vð Þ
where α is a user-specified parameter in the range [0, 1]
that controls the balance between the initial labeling
y and the diffusion of current labels f. This procedure ul-
timately converges to the same optimized node labeling
as the direct algebraic evaluation. The complexity of the
direct algebraic evaluation is at least O((|V| + |U|)2),
while the complexity of the iterative procedure is
O(k|V||U|), where k is the number of iterations required
for convergence. The exact value of k depends on the
properties of the graph as well as the convergence
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than both |V| and |U| even when analyzing large graphs
(>100,000 nodes) with large alpha (>0.9).
The final labeling of the nodes indicates association
with the case or control group. Nodes with scores near +1
are associated with the case group, nodes with scores near
−1 are associated with the control group, and nodes with
scores near 0 are uninformative. For sample nodes, this
score can be viewed as a prediction of case/control status
based on genetic information. For feature nodes, this score
can be interpreted as an association test that can be used
to find biologically significant markers. The feature node
scores may be ordered to obtain a ranking of feature
according to their association with the outcome.
Methods
This section provides details of the datasets and the
experimental design, the evaluation measures we used to
evaluate LP, and the comparison methods including chi
squared, SWRF, and SLR.
Datasets
Synthetic dataset
We created a synthetic dataset containing 1,000 SNPs
and a binary phenotype that is a function of 35 of those
SNPs (“causal” SNVs). Of the 35 SNPs, 10 of them were
modeled as more common SNPs with MAFs that were
sampled uniformly from the range 0.0500 to 0.5000 with
odds ratios in the range 1.05 to 1.50 and 25 SNPS were
modeled as rare SNPs that were sampled uniformly from
the range 0.0001 to 0.0100 and odds ratios in the range
2 to 10. The remaining 965 SNVs (“noise” SNVs) ranged
from common to rare, but do not have an effect on the
disease. Phenotype status was assigned using an additive
threshold model, with each causal SNP conferring an
independent risk of disease. We created a set of 1,000
individuals and in that set 13.3% of individuals had a
positive phenotype. The comparable number of samples
and features make this model fairly robust to variations
across instantiations of the data, reducing the need for
multiple runs to observe “average” statistical performance.
GWAS datasets
We used two different LOAD GWAS datasets. The
first dataset comes from the University of Pittsburgh
Alzheimer’s Disease Research Center (ADRC) [21]. This
dataset consists of 2,229 individuals of which 1,291 were
diagnosed with LOAD and 938 were healthy age-matched
controls. In the original study 1,016,423 SNPS were
measured and after quality controls were applied by the
original investigators 682,685 SNPs located on auto-
somal chromosomes were retained for analysis.
The second dataset comes from the Translational
Genomics Research Institute (TGen) located in Phoenix,Arizona [22]. This dataset consists of three cohorts con-
taining a total of 1,411 individuals of which 861 were di-
agnosed with LOAD and 550 were healthy age-matched
controls. In the original study 502,627 SNPs were mea-
sured for each individual and after quality controls were
applied by the original investigators 234,665 autosomal
SNPs were retained for analysis.
Principal components analysis of each dataset indi-
cated no significant population stratification between the
cases and the controls. Between the datasets, however,
differing allele frequencies are exhibited as indicated by
clustering in the principal components analysis of the
combined data. Because of this, we do not combine the
datasets for a unified analysis, but still use cross-dataset
learning to test generalizability of results.
For the ranking reproducibility and cross-dataset clas-
sification experiments, we retained from both datasets
only those SNPs that were measured in both studies.
There are 64,984 SNPs that are common across the two
datasets. In addition, we performed smaller-scale experi-
ments on SNPs from chromosome 19, which is known
to contain several genetic variants that are associated
with LOAD. There are 13,087 SNPs in chromosome 19 in
the ADRC dataset and 3,652 SNPs in the TGen dataset,
and 1,307 SNPs are common across the two datasets.
Experimental methods
We compared the performance of LP to the perform-
ance of three control methods, which were chi squared,
SWRF, and SLR. We applied the four methods to the
synthetic data to rank SNPs associated with the pheno-
type. After ranking, we plotted precision-recall and ROC
curves to examine how well the truly associated SNPs
were ranked.
For the real data, we applied each method to two
GWAS datasets to rank SNPs that are predictive of
LOAD. We performed the experiments on a small-scale
subset of the data consisting of only those SNPs in
chromosome 19 which contains several well established
LOAD-related SNPs, and on the full genome-wide data.
We evaluated the rankings produced by the four methods
by classification performance and feature reproducibility
across the two datasets. In addition, we examined the top-
ranked SNPs from each method for previous evidence in
the literature that they are associated with LOAD.
Classification performance
Meaningful features should be predictive of disease,
and classifiers developed from highly predictive SNPs
should have good performance in discriminating be-
tween cases and controls. We evaluated the predictive
performance of the top-ranked SNPs for each feature
ranking method and dataset by measuring the per-
formance of a series of classification models that were
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SNPs. Given a set of top-ranked SNPs obtained from a
ranking method applied to a training dataset, we applied
the k-nearest neighbor (kNN) classification method to a test
dataset containing genotypes for the corresponding SNPs.
We evaluated the performance of kNN using fivefold cross-
validation. The dataset was randomly partitioned into five
approximately equal sets such that each set had a similar
proportion of individuals who developed LOAD. We
applied the ranking method on four sets taken together as
the training data, and evaluated the classifer performance
of the top-ranked SNPs on the remaining test data. We
repeated this process for each possible test set to obtain a
LOAD prediction for each individual in the dataset. We
used the predictions to compute the area under the
Receiver Operating Characteristic curve (AUC) which is a
widely used measure of classification performance.
In addition, we performed cross-dataset validation experi-
ments on the filtered dataset containing the common SNPs.
Here, SNPs were ranked on one dataset, and the top-
ranked SNPs were used to derive a kNN classifier on the
other dataset. These experiments show the generalizability
and robustness of the methods, quantifying how well infer-
ence on one dataset can be applied to another cohort.
The LP method is presented with a parameterization of
α = 0.25. This parameterization was selected after testing
several values between 0.1 and 0.9 on the small-scale
TGen dataset. The setting of 0.25 puts more emphasis on
matching the case/control training labels while still utiliz-
ing some network diffusion, and is suitable for finding dis-
criminative SNPs. Smaller values of alpha lead to rankings
that are indistinct from the chi squared test, while larger
values lead to uninformative, uniform feature scores.
Feature reproducibility
With the predictive power of the top-ranked SNPs
established, we evaluated the feature ranking methods
for reproducibility across the two datasets. For the
genome-wide datasets, we reduced them so that they
contained only the genotypes for the 64,984 SNPs that
were common to both. We ran each feature ranking
method separately on each of the reduced datasets and
examined the ranked SNPs for reproducibility. Given
two ranked list of SNPs obtained by applying a feature
ranking method to the two reduced datasets we examined
the ranked lists for common SNPs in the top-ranked 10
SNPs, 50 SNPs, 100 SNPs, and so on. Reproducibility was
calculated as the number of SNPs in common to both lists
divided by the total number of SNPs in a list, yielding a
value in the range from 0 (no SNPs in common) to 1 (both
lists contain exactly the same SNPs). This metric only
checks for presence or absence of SNP in a list, and
ignores actual ranks within the list. The LP method is pre-
sented for multiple setting of α, ranging from 0.25 to 0.9.Evidence from the literature
We examined the top-ranked SNPs for biological signifi-
cance and evidence of previously documented associ-
ation with LOAD. We used several publically available
databases and resources including SNPedia [23], Gene-
Cards [24], and dbSNP [25] to search for links between
the variants and LOAD. In addition to SNPs directly
named in the literature as having an association with
LOAD, we also considered a wider degree of plausible
associations. For each SNP, we searched whether it was
in strong linkage disequilibrium with LOAD-related
SNPs, whether the SNP was in a LOAD-related gene,
whether the associated gene was part of a strongly con-
served, LOAD-related family, or whether the variant has
been associated with brain development or other neuro-
logical conditions.
Computational efficiency
We ran all four methods on a PC with a 2.33 GHz Intel
processor and 4 GB of RAM. All methods were imple-
mented in Java, except for the SLR method, which is
a MATLAB package [10]. For each feature ranking
method, we recorded the time required to score fea-
tures on one training fold of the ADRC dataset.
Results
Synthetic data
Figure 2 shows the precision-recall and ROC curves
obtained from the four ranking methods on the synthetic
dataset. All methods do quite well in retrieving the 35
causal SNPs. The SLR method performs the best on this
dataset, showing excellent retrieval even for small-effect
SNPs. The other methods perform well, identifying nearly
all of the large-effect SNPs at the top of the ranking. The
small-effect size SNPs fall somewhat lower in the ranking,
as indicated by the tail in the precision-recall graphs for
three of the methods. All four methods perform similarly
in the ROC space, achieving similar true positive rates for
a given false positive rate. The shape of the ROC graph
again indicates that all of the methods rank most of the
valid SNPs at the top of the list, but only find the small-
effect size SNPs after many false positives. These results
provide support that each of the methods is able to find
valid associations in SNP data over a range of MAFs and
effect sizes.
GWAS classification performance
Figure 3 shows the AUCs obtained for the four ranking
methods obtained from application of the kNN classifier
on the two LOAD datasets. Generally, LP achieves equal
or higher AUCs than chi squared and SWRF, and similar
AUCs to SLR. On the small-scale datasets (containing
chromosome 19 SNPs only) LP achieves statistically
significantly higher AUCs at the 5% significance level
Figure 2 Precision-recall and ROC curves for four feature ranking methods on synthetic data. There are 35 true phenotype-associated
SNPs in this dataset.
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from 10 to 1000 top-ranked SNPs (see Table 1). On the
genome-wide datasets, similar statistically significantly
higher AUCs were achieved by LP in the range from 50
to 100 top-ranked SNPs (see Table 1). LP has a statisti-
cally significantly lower AUC than chi squared or
SWRF in only two experiments, when using just 1 or 2
SNPs in the ADRC dataset. When using at least 10
SNPs, LP always significantly outperforms either chi








































Figure 3 AUCs with 95% confidence intervals for four different feat
from application of the kNN classifier on two LOAD datasets (TGen a
genome-wide). The datasets used in the four panels are: A) TGen chromoso
chromosome 19 only (13,087 SNPs); D) ADRC genome-wide (682,685 SNPs). Tperform significantly differently from LP in all experi-
ments that use more than one SNP for classification.
For all four ranking methods, the classification per-
formance shows the general trend of higher AUCs with
a moderate number of SNPs used in the classifier, and
lower AUCs at very small and very large numbers of
SNPs. Compared to the other methods, LP’s perform-
ance drops far more slowly with increasing the number
of SNPs in the classifier. This is a useful property for a
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he SLR method implicitly selects <500 features in each experiment.
Table 1 Prediction results for feature ranking methods (chi squared, SWRF, SLR and LP) on two LOAD datasets (TGen and ADRC) with two sets of SNPs
(chromosome 19 only and genome-wide)
Dataset # SNPs Method Number of SNPs used in classifier
1 2 5 10 50 100 500 1000
TGen 3,652 (chr19) Chi Sq 0.6628 ± 0.0284 0.6791 ± 0.0278 0.6811 ± 0.0280 0.6567 ± 0.0290 0.5768 ± 0.0306 0.5925 ± 0.0300 0.5627 ± 0.0306 0.5512 ± 0.0304
SWRF 0.6783 ± 0.0284 0.6778 ± 0.0284 0.6791 ± 0.0282 0.6697 ± 0.0286 0.6620 ± 0.0286 0.6280 ± 0.0290 0.5941 ± 0.0304 0.5691 ± 0.0306
SLR 0.5014 ± 0.0302 0.6821 ± 0.0282 0.7129 ± 0.0270 0.7170 ± 0.0269 0.6847 ± 0.0282 0.6747 ± 0.0286 * *
LP 0.6733 ± 0.0284 0.6904 ± 0.0278 0.7080 ± 0.0270 0.7184 ± 0.0267 0.7093 ± 0.0270 0.6945 ± 0.0274 0.6246 ± 0.0298 0.5989 ± 0.0302
234,665 (chr1-22) Chi Sq 0.6628 ± 0.0284 0.6991 ± 0.0274 0.7230 ± 0.0267 0.7310 ± 0.0263 0.7068 ± 0.0272 0.6549 ± 0.0292 0.6059 ± 0.0302 0.5990 ± 0.0302
SWRF 0.6640 ± 0.0284 0.6705 ± 0.0284 0.7020 ± 0.0280 0.6796 ± 0.0286 0.6749 ± 0.0284 0.6087 ± 0.0306 0.5447 ± 0.0253 0.5261 ± 0.0169
SLR 0.6783 ± 0.0284 0.7076 ± 0.0270 0.7291 ± 0.0261 0.7424 ± 0.0257 0.7464 ± 0.0257 * * *
LP 0.6733 ± 0.0284 0.6904 ± 0.0284 0.7088 ± 0.0269 0.7396 ± 0.0257 0.7519 ± 0.0251 0.7286 ± 0.0270 0.6138 ± 0.0237 0.5735 ± 0.0178
ADRC 13,087 (chr19) Chi Sq 0.6834 ± 0.0220 0.7369 ± 0.0206 0.7433 ± 0.0204 0.7169 ± 0.0212 0.6446 ± 0.0229 0.6109 ± 0.0233 0.5282 ± 0.0239 0.5361 ± 0.0241
SWRF 0.6834 ± 0.0229 0.7006 ± 0.0221 0.7169 ± 0.0206 0.7122 ± 0.0206 0.6894 ± 0.0220 0.6580 ± 0.0225 0.5343 ± 0.0235 0.4965 ± 0.0239
SLR 0.6834 ± 0.0220 0.6855 ± 0.0218 0.6964 ± 0.0216 0.7068 ± 0.0213 0.7041 ± 0.0213 0.6478 ± 0.0227 * *
LP 0.6325 ± 0.0220 0.6756 ± 0.0214 0.7342 ± 0.0210 0.7378 ± 0.0212 0.6894 ± 0.0218 0.6616 ± 0.0225 0.6095 ± 0.0241 0.5687 ± 0.0239
682,685 (chr1-22) Chi Sq 0.6834 ± 0.0220 0.7369 ± 0.0206 0.7433 ± 0.0204 0.7184 ± 0.0212 0.6438 ± 0.0227 0.6034 ± 0.0235 0.5445 ± 0.0239 0.5349 ± 0.0239
SWRF 0.6834 ± 0.0220 0.7006 ± 0.0213 0.6978 ± 0.0216 0.6934 ± 0.0220 0.6851 ± 0.0220 0.6293 ± 0.0231 0.5160 ± 0.0178 0.5029 ± 0.0127
SLR 0.6834 ± 0.0220 0.6911 ± 0.0218 0.7100 ± 0.0214 0.7354 ± 0.0206 0.6970 ± 0.0218 0.6874 ± 0.0220 * *
LP 0.6325 ± 0.0229 0.6756 ± 0.0221 0.7342 ± 0.0206 0.7315 ± 0.0206 0.7151 ± 0.0210 0.7145 ± 0.0214 0.6096 ± 0.0204 0.5435 ± 0.0122
The entries are the cross-fold classification AUCs and the 95% confidence intervals obtained from application of the kNN classifier to a specified number of top-ranked SNPs. Bold cells indicate where LP significantly
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http://www.biomedcentral.com/1471-2164/15/282to be used in a classifier can be a difficult number to
choose. With too few features relevant SNPs may be
missed, and with too many features irrelevant SNPs may
be included. The LP method picks features which limit
the amount of noise introduced, widening the useful
performance range of the classifier. This reduces the
chance of missing a relevant biomarker because of an
overly restrictive feature selection threshold.
Results for the cross-dataset experiments are found
in Table 2. Similar classification AUCs to the cross-
validated experiments indicate that the selected features
are robust between datasets, having meaning even in
other patient cohorts. Several algorithms have trouble
identifying a useful SNP in the #1 rank, possibly ex-
plained by stratification between the patient populations.
Good performance is quickly achieved, however, provid-
ing further support that the selected variants are valid.
GWAS feature reproducibility
Figure 4 shows the reproducibility results on the small-
scale and genome-wide datasets. Chi squared identifies the
first few SNPs reproducibly; these are SNPs that are located
in genes apolipoprotein-E (APOE) and apolipoprotein-C
(APOC) and are known to have large effects sizes. Beyond
the first few SNPs, however, the reproducibility of chi
squared drops rapidly to a level which is effectively random.
The SWRF method produces somewhat reproducible re-
sults in the small-scale chromosome 19 datasets, but is no
better than random for the genome-wide datasets. The SLR
method selects on the order of 100 SNPs for each filtered
dataset, and is not shown on the reproducibility graph. For
each SLR experiment, there are only two overlapping SNPs
in each selected list, which are the two major loci on APOE.
All other SNPs selected by SLR are not reproduced from
one dataset to another. LP, in contrast to these methods,
shows good reproducibility for many of the top-ranked
SNPs, and does so even in the high-dimensional datasets.
The method has low reproducibility for the first few SNPs
but quickly surpasses chi squared, SWRF, and SLR. For
higher values of α, LP has higher reproducibility. For α
close to 0, diffusion of labels plays a small role in deter-
mining the ranking and LP behaves like a supervised
method that computes a correlation measure. When α is
close to 1, label diffusion has a greater effect on the rank-
ing, and clusters in the data have a greater effect, yielding
higher reproducibility. By utilizing the dense connected-
ness of nodes in modules of SNPs, LP produces more re-
producible results.
Evidence from the literature
Among the 25 top-ranked SNPs, several SNPs have
previously known AD associations or have evidence for
biologically plausibility of being involved in AD (see
Additional file 1 for SNP lists). For both datasets, LPidentified the highest number of plausibly associated
SNPs. In the TGen dataset, 14 of top 25 SNPs identified
by LP had evidence of being associated with LOAD,
whether through direct association tests, co-location in as-
sociated genes, or through functional effects. In contrast,
only 6 of the top 25 SNPs identified by chi squared had
evidence of being associated with LOAD, SLR identified 7
associated SNPs, and SWRF identified 5 associated SNPs.
In the ADRC dataset, 10 of the top 25 SNPs identified by
LP had evidence of being associated with LOAD. Chi
squared also identified 10 LOAD-related SNPs among the
top 25; however, 7 of them are from a tightly clustered
group of SNPs in chromosome 19 near the APOE locus,
and do not represent a diverse genetic signal. SLR finds 5
associated SNPs in the ADRC data, and SWRF finds only
2. For both datasets, the remaining SNPs not found in the
literature are generally located in relatively unstudied
intergenic regions of the genome.
Computational efficiency
Of the four ranking methods, chi squared is the fastest
and took approximately 4 minutes to run on one train-
ing fold for the ADRC dataset. The SWRF method was
the slowest and took almost 2 days to run. The SLR
method was also slow, taking 11 hours and 29 minutes
to complete. LP ran in 26 minutes for α = 0.25, and took
72 minutes for α = 0.9.
Discussion
The results on the synthetic data show that LP performs
comparably to the control methods that included chi
squared, SWRF, and SLR. The SLR method performed
particularly well in identifying small-effect SNPs in the
synthetic data compared to LP and the other control
methods. On the GWAS datasets, LP performed signifi-
cantly better than chi squared and SWRF in terms of
classification performance, reproducibility, and identified
more SNPs among the top 25 ranked SNPs that had
prior evidence of being associated with LOAD. When
compared to SLR, LP had similar classification perform-
ance, but had better reproducibility and identified more
SNPs among the top 25 ranked SNPs that had prior
evidence of being associated with LOAD. In terms of
computational efficiency LP is somewhat slower than
chi squared, but is significantly faster than SWRF and
SLR, and is sufficiently fast that it can be effectively
applied to real genome-wide datasets. Overall, LP per-
forms better than each of the control algorithms in one
or more of the performance metrics tested, and does
not perform significantly worse in any of them.
LP’s top-ranked features are reproducible across data-
sets, and provide good classification performance. The
underlying genetic mechanisms and patterns of inherit-
ance used in the graph-based LP method are also not as
Table 2 Prediction AUCs for cross-dataset experiments
Dataset # SNPs Method Number of SNPs used in classifier





Chi Sq 0.6086 ± 0.0294 0.6863 ± 0.0280 0.7099 ± 0.0270 0.6958 ± 0.0253 0.6563 ± 0.0286 0.6097 ± 0.0296 0.5593 ± 0.0310 0.5563 ± 0.0308
SWRF 0.5952 ± 0.0296 0.6980 ± 0.0274 0.6994 ± 0.0272 0.7005 ± 0.0274 0.6756 ± 0.0284 0.6677 ± 0.0284 0.5635 ± 0.0306 0.5195 ± 0.0310
SLR 0.6086 ± 0.0294 0.6863 ± 0.0280 0.7164 ± 0.0269 0.7289 ± 0.0263 0.6522 ± 0.0292 0.6084 ± 0.0300 * *





Chi Sq 0.6172 ± 0.0231 0.6385 ± 0.0229 0.7419 ± 0.0204 0.7362 ± 0.0208 0.6695 ± 0.0225 0.6479 ± 0.0227 0.5396 ± 0.0239 0.5259 ± 0.0122
SWRF 0.5397 ± 0.0239 0.5345 ± 0.0241 0.5350 ± 0.0241 0.5401 ± 0.0243 0.5042 ± 0.0243 0.5257 ± 0.0241 0.5201 ± 0.0241 0.5053 ± 0.0241
SLR 0.5397 ± 0.0214 0.7006 ± 0.0214 0.7003 ± 0.0214 0.7048 ± 0.0216 0.6048 ± 0.0233 0.5854 ± 0.0237 * *
LP 0.5397 ± 0.0239 0.6021 ± 0.0235 0.7283 ± 0.0210 0.7366 ± 0.0208 0.6853 ± 0.0220 0.6598 ± 0.0225 0.5678 ± 0.0239 0.5306 ± 0.0239
The entries are the cross-dataset classification AUCs and the 95% confidence intervals. Feature selection was applied to one dataset, and the top-ranked features were used to derive and evaluate a kNN classifier on



















Figure 4 Reproducibility curves of top-ranked features shown for top 50% of features (95% confidence interval), with callout for top
5% of features (CI omitted for clarity). The x-axis shows the fraction of top-ranked features being considered, and the y-axis shows the fraction
of features in common to rankings obtained from each of the two datasets independently (TGen and ADRC). The datasets used are: A) small-scale
TGen and ADRC overlap data (chr19, 1,307 SNPs); B) genome-wide TGen and ADRC overlap data (chr 1–22, 64,984 SNPs). For this plot, the chi squared
and SWRF methods are virtually indistinguishable from the random performance curve along the diagonal. SLR is omitted because it selects less than
0.5% of features with almost no reproducibility.
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http://www.biomedcentral.com/1471-2164/15/282susceptible to changes in experimental protocol as more
traditional methods. In contrast, chi squared computes a
univariate statistic for each SNP, and is susceptible to
errors in the data (misdiagnosed case/control status,
misread genotype). LP, on the other hand, produces a
score that depends on the distribution of all variants
throughout the dataset. This score is not as susceptible
to small errors because the largely correct training infor-
mation is able to diffuse across the network and mitigate
mistakes.
The network propagation method also allows for more
diverse genetic signals to be scored highly. Chi squared
ranks SNPs in strong LD closely together because it
operates solely on the observational data counts. LP, on
the other hand, can propagate influence from other
parts of the network through sample nodes, meaning
that even SNPs exhibited by mostly the same individuals
can get different scores.The LP method can be extended to handle signifi-
cantly stratified data by using correction factors as
described in [26]. In this method, principal components
of variation are determined, and phenotypes and geno-
types are adjusted to zero out this variation. Phenotype
adjustment is simple, requiring only a re-labeling of the
sample nodes. Genotype adjustment in LP is more com-
plex, requiring edge weights other than 0 and 1 to be
encoded.
One limitation of this paper is that we examined only
two datasets related to a single disease. In future
research, we plan to investigate the performance of LP
on additional LOAD GWAS datasets as well as GWAS
datasets from other diseases.
Conclusions
Biomarker discovery in GWAS data is a challenging
problem with the potential for many false positives
Stokes et al. BMC Genomics 2014, 15:282 Page 12 of 13
http://www.biomedcentral.com/1471-2164/15/282and the lack of reproducibility across datasets. LP had
excellent comparative performance among the four
feature ranking methods we applied in this paper,
based on the results of classification accuracy, repro-
ducibility, biological validity, and running time. The LP
method is effective in all of these performance mea-
sures across a range of experimental conditions, while
the other methods tested are weak in at least one of
these areas. These results provide support for includ-
ing LP in the methods that are used to rank SNPs in
high-dimensional GWAS datasets.
Additional file
Additional file 1: Top 25 SNPs as ranked by each algorithm
(chi squared, SWRF, LR, and LP) on two LOAD datasets (TGen and
ADRC). Each SNP rsID is listed with the associated chromosome and
gene, as well as any connection to LOAD in the literature.
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